PRDX1 and colorectal carcinoma: In conclusion, we found that miR-431-5p served as a predictive role in CRC patients’ prognosis, and upregulated miR-431-5p conveyed by hUCMSC-Exos suppresses CRC progression by inhibiting PRDX1.